Cargando…
Probiotics as a Treatment for “Metabolic Depression”? A Rationale for Future Studies
Depression and metabolic diseases often coexist, having several features in common, e.g., chronic low-grade inflammation and intestinal dysbiosis. Different microbiota interventions have been proposed to be used as a treatment for these disorders. In the paper, we review the efficacy of probiotics i...
Autores principales: | Gawlik-Kotelnicka, Oliwia, Strzelecki, Dominik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074252/ https://www.ncbi.nlm.nih.gov/pubmed/33924064 http://dx.doi.org/10.3390/ph14040384 |
Ejemplares similares
-
Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap
por: Gawlik-Kotelnicka, Oliwia, et al.
Publicado: (2021) -
The Influence of Probiotic Supplementation on the Severity of Anxiety and Depressive Symptoms; Function and Composition of Gut Microbiota; and Metabolic, Inflammation, and Oxidative Stress Markers in Patients with Depression—A Study Protocol
por: Skowrońska, Anna, et al.
Publicado: (2023) -
PRO-DEMET Randomized Controlled Trial on Probiotics in Depression—Pilot Study Results
por: Gawlik-Kotelnicka, Oliwia, et al.
Publicado: (2023) -
Ghrelin as a Biomarker of “Immunometabolic Depression” and Its Connection with Dysbiosis
por: Gajewska, Agata, et al.
Publicado: (2023) -
“Leaky Gut” as a Keystone of the Connection between Depression and Obstructive Sleep Apnea Syndrome? A Rationale and Study Design
por: Gawlik-Kotelnicka, Oliwia, et al.
Publicado: (2022)